Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,803 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,155 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03667417 | Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation(GENEPSO) | recruiting | — | 5,000 | Institut Paoli-CalmettesOTHER | 1 | Jul 1, 2020 | clinicaltrials |
| NCT04453904 | Modality of Adjuvant Radiotherapy and Chemotherapy for Stage Ⅲ Endometrial Cancer | recruiting | N/A | 654 | Peking University People's HospitalOTHER | 1 | Jul 1, 2020 |
| clinicaltrials |
| NCT03294889 | ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer | recruiting | Phase 1 / Phase 2 | 45 | University Hospital, GenevaOTHER | 1 | May 14, 2020 | clinicaltrials |
| NCT04227249 | 3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer(TREE PRO) | not yet recruiting | — | 153 | Seoul National University HospitalOTHER | 0 | Jan 14, 2020 | clinicaltrials |
| NCT04212715 | Prostate SABR With Intra-Prostatic SABR Boost | recruiting | Phase 2 | 30 | King Saud UniversityOTHER | 1 | Jan 2, 2020 | clinicaltrials |
| NCT04197414 | Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA | recruiting | — | 3,000 | Yonsei UniversityOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT04172753 | Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac | recruiting | N/A | 472 | University Hospital TuebingenOTHER | 1 | Nov 21, 2019 | clinicaltrials |
| NCT02724670 | Study of MR-based IGRT for Prostate Cancer(M-basePro) | recruiting | N/A | 78 | University Hospital TuebingenOTHER | 1 | Sep 25, 2019 | clinicaltrials |
| NCT04079699 | Predicting Prostate Cancer in Elderly Men | not yet recruiting | N/A | 700 | Odense University HospitalOTHER | 0 | Sep 6, 2019 | clinicaltrials |
| NCT04063527 | Phase III Trial of Stage I Ovarian Cancer After Surgery | recruiting | Phase 3 | 360 | Japanese Gynecologic Oncology GroupOTHER | 2 | Aug 30, 2019 | clinicaltrials |
| NCT02971085 | Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active Surveillance(SUPER-PC-AS) | recruiting | — | 410 | Seoul National University HospitalOTHER | 1 | Feb 12, 2019 | clinicaltrials |
| NCT01194648 | Focal Therapy for Prostate Cancer Using HIFU(INDEX) | recruiting | N/A | 354 | University College, LondonOTHER | 1 | Apr 20, 2018 | clinicaltrials |
| NCT02865330 | Spanish Urological Association Registry of Patients on Active Surveillance | recruiting | — | 946 | Fundación Instituto Valenciano de OncologíaOTHER | 1 | Feb 12, 2018 | clinicaltrials |
| NCT03392233 | Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors | recruiting | Phase 2 | 100 | RenJi HospitalOTHER | 1 | Jan 5, 2018 | clinicaltrials |
| NCT03249519 | Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer | recruiting | N/A | 999 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Aug 15, 2017 | clinicaltrials |
| NCT02391051 | Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial(FOKAL-BT) | recruiting | Phase 2 | 50 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Aug 11, 2017 | clinicaltrials |
| NCT01000259 | Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer | recruiting | — | 174 | Gynecologic Oncology GroupNETWORK | 1 | May 5, 2017 | clinicaltrials |
| NCT02543710 | Biomarker Guided Treatment in Gynaecological Cancer(Momatec2) | recruiting | Phase 4 | 1,300 | Haukeland University HospitalOTHER | 3 | Mar 28, 2017 | clinicaltrials |
| NCT02487693 | Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma | active not recruiting | Phase 2 | 50 | The First People's Hospital of ChangzhouOTHER | 0 | Feb 23, 2016 | clinicaltrials |
| NCT02490748 | Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer | active not recruiting | Phase 2 | 10 | The First People's Hospital of ChangzhouOTHER | 0 | Feb 23, 2016 | clinicaltrials |
Data updated 22 days agoSource updated Jul 1, 2020source: clinicaltrials